CHEMICAL ADDRESS TAGS: A Cheminformatic & Image Data Management and Analysis Plan
Project Number5R01GM078200-02
Contact PI/Project LeaderROSANIA, GUS R
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
DESCRIPTION (provided by applicant): Adverse drug reactions (ADRs) are one of the leading causes of hospitalization and death in the United States. ADRs are often associated with unfavorable drug bioavailability or biodistribution profiles. Thus, ADRs could be prevented by optimizing drug transport properties -from the systemic, organ level down to the microscopic, cellular level. To improve the quality of drugs entering clinical trials, a new generation of microscopic imaging instruments -known as "high content screening" or "HCS" systems has been developed. HCS instruments can provide preclinical, human cell-based data to complement animal studies in predictive toxicology testing. As a high-throughput platform, HCS systems can be used to screen large collections of small molecules in physiologically-relevant assays. Now the challenge is to incorporate HCS technology into standard biomedical research practice, to facilitate discovery of less toxic drug candidates with improved clinical success rates. To meet this challenge, we propose to develop a cheminformatic and image data management and analysis plan to study the subcellular localization of fluorescent, small molecules -in living cells. Inspired by machine vision approaches currently being used as a tool to analyze the subcellular distribution of proteins on a genome-wide scale ("location proteomics"), we propose that machine vision could also be adopted as a tool to analyze the distribution of small molecule fluorescent drug candidates. In analogy to how protein location is encoded by signal peptides, we hypothesize that subcellular small molecule localization is encoded by "Chemical Address Tags" to be discovered within the chemical structure of small molecules. To test this hypothesis, we plan to: 1) Develop automated, image analysis and cheminformatic tools to reverse- engineer Chemical Address Tags in an objective, quantitative and high-throughput manner; 2) Develop and compare two quantitative, machine vision approaches to assay the transport properties of mitochondria- targeting molecules; 3) Demonstrate how a cheminformatics-driven, image data management and analysis plan can impact an anticancer drug lead optimization effort.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdoptedAdverse reactionsAnimalsAntineoplastic AgentsBehaviorBiodistributionBiological AssayBiological AvailabilityBiomedical ResearchCellsCessation of lifeChemical EngineeringChemical StructureChemicalsClinicalClinical TrialsCollectionComplementData SetDatabasesDoseDrug TransportDrug toxicityEngineeringGenerationsGenomeHalf-LifeHospitalizationHumanHuman Placental LactogenImageImage AnalysisImaging TechniquesKineticsLeadLibrariesLifeLiving WillsLocationMediatingMicroscopicMitochondriaModelingMonitorMulti-Drug ResistanceNormal CellOpticsOrganP-GlycoproteinP-GlycoproteinsPeptide Signal SequencesPharmaceutical PreparationsPropertyProteinsProteomicsRateReactionReaction TimeResearch PersonnelScreening procedureStandards of Weights and MeasuresSystemTechnologyTestingToxicologyUnited StatesVisionWorkanalogbasecancer cellcell killingcheminformaticsdata managementdesigndrug qualityextracellularimprovedinstrumentkillingspre-clinicalpreventprogramsprotein distributionresearch studysmall moleculespatiotemporalsuccesstooluptake
No Sub Projects information available for 5R01GM078200-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM078200-02
Patents
No Patents information available for 5R01GM078200-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM078200-02
Clinical Studies
No Clinical Studies information available for 5R01GM078200-02
News and More
Related News Releases
No news release information available for 5R01GM078200-02
History
No Historical information available for 5R01GM078200-02
Similar Projects
No Similar Projects information available for 5R01GM078200-02